• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Case report: development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-alpha.

作者信息

Hirashima N, Mizokami M, Orito E, Koide T, Itazu I, Kumada K, Sakakibara K, Kano H, Lau J Y

机构信息

Department of Gastroenterology, Chukyo Hospital, Nagoya City University Medical School, Japan.

出版信息

J Gastroenterol Hepatol. 1996 Oct;11(10):955-8.

PMID:8912134
Abstract

A 60-year-old man with a chronic hepatitis C virus (HCV) infection and histological features of chronic active hepatitis was treated with interferon-alpha (IFN). He successfully responded to IFN with normalization of serum ALT and disappearance of serum HCV-RNA. His liver biochemistry profile remained normal and serum HCV-RNA was not detected throughout the entire follow-up period. One year later, a small hepatocellular carcinoma (HCC) was detected by routine ultrasonographic screening. Laparotomy revealed a small tumour with no metastasis and the non-tumorous liver demonstrated macronodular cirrhosis. Although no space-occupying lesions were detected by frequent radiological examinations prior to IFN therapy, the small size of the tumour suggested de novo development of HCC. Patients with chronic HCV infection, including those who have complete responses to IFN and lack clinical and histological evidence of cirrhosis, should be followed up for the potential development of HCC.

摘要

相似文献

1
Case report: development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-alpha.
J Gastroenterol Hepatol. 1996 Oct;11(10):955-8.
2
Hepatocellular carcinoma developed in a patient with chronic hepatitis C after the disappearance of hepatitis C virus due to interferon therapy.一名慢性丙型肝炎患者在接受干扰素治疗后丙型肝炎病毒消失,随后发生了肝细胞癌。
Hepatogastroenterology. 1999 Jul-Aug;46(28):2554-60.
3
Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma?丙型肝炎病毒相关性肝硬化患者干扰素治疗的长期评估:干扰素能否预防肝细胞癌的发生?
Oncol Rep. 1998 Jan-Feb;5(1):205-8.
4
A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy.一名丙型肝炎相关肝硬化和肝细胞癌患者,接受原位肝移植和干扰素治疗后治愈。
J Gastroenterol. 2003;38(6):598-602.
5
Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease.丙型肝炎病毒相关慢性肝病中的庚型肝炎病毒感染及对干扰素的治疗反应
Southeast Asian J Trop Med Public Health. 1998 Sep;29(3):480-90.
6
Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.慢性丙型肝炎患者对干扰素治疗反应不同,肝硬化和肝细胞癌的发病率各异。
Cancer. 1999 May 1;85(9):1943-50.
7
Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy.在对干扰素治疗获得持续病毒学应答的慢性丙型肝炎患者中肝细胞癌发生的危险因素。
J Gastroenterol Hepatol. 2005 May;20(5):752-8. doi: 10.1111/j.1440-1746.2005.03800.x.
8
[Viral hepatitis C].[丙型病毒性肝炎]
Z Gastroenterol. 1995 Feb;33(2):117-32.
9
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin.丙型肝炎病毒相关慢性肝病患者在对干扰素和利巴韦林实现持续病毒学应答90个月和70个月后的肝细胞癌表现。
Liver Int. 2008 Mar;28(3):407-11. doi: 10.1111/j.1478-3231.2007.01593.x. Epub 2007 Sep 26.
10
[Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].[干扰素治疗在丙型肝炎病毒相关肝细胞癌治疗中的临床意义]
Gan To Kagaku Ryoho. 2001 Dec;28(13):1975-9.

引用本文的文献

1
Development of a hepatocellular carcinoma in a chronic hepatitis C patient 18 years after achieving a sustained virological response to interferon therapy: case report and literature review.一名慢性丙型肝炎患者在干扰素治疗获得持续病毒学应答18年后发生肝细胞癌:病例报告及文献综述
Clin J Gastroenterol. 2012 Apr;5(2):119-26. doi: 10.1007/s12328-012-0284-7. Epub 2012 Feb 18.
2
Development of hepatocellular carcinoma in patients with chronic hepatitis C more than 10 years after sustained virological response to interferon therapy.慢性丙型肝炎患者在对干扰素治疗获得持续病毒学应答10年以上后发生肝细胞癌。
Oncol Lett. 2010 May;1(3):427-430. doi: 10.3892/ol_00000075. Epub 2010 May 1.
3
Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C.
在慢性丙型肝炎患者中,肝脂肪变性可能是抗病毒治疗清除丙型肝炎病毒后发生肝细胞癌的一个风险因素。
World J Gastroenterol. 2007 Oct 21;13(39):5180-7. doi: 10.3748/wjg.v13.i39.5180.
4
Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.丙肝病毒经干扰素治疗清除后肝细胞癌的发生
West J Med. 1997 Aug;167(2):103-5.